A small group of older Boston Scientific (NYSE:BSX) subcutaneous implantable cardioverter defibrillators have an increased risk of early battery depletion, the company said this month in an advisory letter to physicians. The Marlborough, Mass.-based company said the issue affects about 400 (0.7%) of its Emblem S-ICD and Emblem MRI S-ICD devices. Those devices have “an elevated […]